BIOT

Biotech Acquisition Company Class A Ordinary Shares
BIOT

Delisted

BIOT was delisted on the 2nd of February, 2023.

Back to rankings

51 hedge funds and large institutions have $121M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$86K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.57M
2
+$5.7M
3
+$4.98M
4
DCM
DG Capital Management
New York
+$4.35M
5
RCM
Radcliffe Capital Management
Pennsylvania
+$3.92M

Top Sellers

1
-$2.92M
2
-$1.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$8.97M
2
$8.68M
3
$7.35M
4
$6.57M
5
$5.8M
6
$5.7M
7
$5.38M
8
$4.83M
9
$4.35M
10
$3.92M
11
$3.87M
12
$3.86M
13
$3.79M
14
$3.77M
15
$3.07M
16
$2.9M
17
$2.9M
18
$2.42M
19
$2.4M
20
$2.27M
21
$1.94M
22
$1.93M
23
$1.8M
24
$1.78M
25
$1.61M
1
2 3